Abstract
Purpose
The synthetic 15 amino acid biomimetic peptide sequence (P15) derived from a region of the alpha (α)-1 chain of collagen I, has been shown to promote α2 integrin activation and enhance intramembranous ossification. In this study, we ask if the P15 peptide also enhances bone formation through endochondral ossification, and determine if direct binding of α2 integrin with P15 mediates integrin activation.
Methods
Mesenchymal cells (C3H10T1/2) were cultured in chondrogenic media and the expression of chondrogenic markers and integrin activation was determined by Western blot and fluorescent immunohistochemistry. A biosensor assay was used to determine if binding occurred between P15 and α2 β1 integrin. Finally, an in vivo model of endochondral ossification was used to determine the effect of P15 on bone formation.
Results
In the presence of P15, chondrogenesis and activation of α5 integrin were enhanced, as observed by both Western blot analysis and immunoflourescent staining. A biosensor assay investigating the specificity of the interaction between P15 with α2β1 integrin determined direct binding does not occur. When P15 was added to Matrigel implanted in a murine endochondral ossification model, in the presence of bone morphogenic protein-2 (BMP-2), a significant increase in chondrocyte differentiation and mineralization was observed.
Conclusion
P15 does not directly activate integrins by binding, but does upregulate integrin signaling to enhance differentiation of both osteoblasts and chondrocytes to increase both intramembranous and endochondral bone formation.
Similar content being viewed by others
References
Deyo RA, Gray DT, Kreuter W, Mirza S, Martin BI (2005) United States trends in lumbar fusion surgery for degenerative conditions. Spine 30(12):1441–1445, discussion 1446-1447
Siu RK, Lu SS, Li W, Whang J, McNeill G, Zhang X, Wu BM, Turner AS, Seim HB 3rd, Hoang P, Wang JC, Gertzman AA, Ting K, Soo C (2011) Nell-1 protein promotes bone formation in a sheep spinal fusion model. Tissue Eng Part A 17(7-8):1123–1135. doi:10.1089/ten.TEA.2010.0486
Reid JJ, Johnson JS, Wang JC (2011) Challenges to bone formation in spinal fusion. J Biomech 44(2):213–220. doi:10.1016/j.jbiomech.2010.10.021
Nerubay J, Marganit B, Bubis JJ, Tadmor A, Katznelson A (1986) Stimulation of bone formation by electrical current on spinal fusion. Spine 11(2):167–169
Chang CF, Lee MW, Kuo PY, Wang YJ, Tu YH, Hung SC (2007) Three-dimensional collagen fiber remodeling by mesenchymal stem cells requires the integrin-matrix interaction. J Biomed Mater Res A 80(2):466–474. doi:10.1002/jbm.a.30963
Franceschi RT, Ge C, Xiao G, Roca H, Jiang D (2009) Transcriptional regulation of osteoblasts. Cells Tissues Organs 189(1-4):144–152. doi:10.1159/000151747
Myllyharju J, Kivirikko KI (2004) Collagens, modifying enzymes and their mutations in humans, flies and worms. Trends Genet 20(1):33–43. doi:10.1016/j.tig.2003.11.004
Liu Q, Limthongkul W, Sidhu G, Zhang J, Vaccaro A, Shenck R, Hickok N, Shapiro I, Freeman T (2012) Covalent attachment of P15 peptide to titanium surfaces enhances cell attachment, spreading, and osteogenic gene expression. J Orthop Res Off Publ Orthop Res Soc 30(10):1626–1633. doi:10.1002/jor.22116
Gomar F, Orozco R, Villar JL, Arrizabalaga F (2007) P-15 small peptide bone graft substitute in the treatment of non-unions and delayed union. A pilot clinical trial. Int Orthop 31(1):93–99. doi:10.1007/s00264-006-0087-x
Yang XB, Bhatnagar RS, Li S, Oreffo RO (2004) Biomimetic collagen scaffolds for human bone cell growth and differentiation. Tissue Eng 10(7-8):1148–1159. doi:10.1089/ten.2004.10.1148
Lee JY, Choi YS, Lee SJ, Chung CP, Park YJ (2011) Bioactive peptide-modified biomaterials for bone regeneration. Curr Pharm Des 17(25):2663–2676
Thorwarth M, Schultze-Mosgau S, Wehrhan F, Kessler P, Srour S, Wiltfang J, Andreas Schlegel K (2005) Bioactivation of an anorganic bone matrix by P-15 peptide for the promotion of early bone formation. Biomaterials 26(28):5648–5657. doi:10.1016/j.biomaterials.2005.02.023
Bhatnagar RS, Qian JJ, Wedrychowska A, Sadeghi M, Wu YM, Smith N (1999) Design of biomimetic habitats for tissue engineering with P-15, a synthetic peptide analogue of collagen. Tissue Eng 5(1):53–65
Mobbs RJ, Maharaj M, Rao PJ (2014) Clinical outcomes and fusion rates following anterior lumbar interbody fusion with bone graft substitute i-FACTOR, an anorganic bone matrix/P-15 composite. J Neurosurg Spine 21(6):867–876. doi:10.3171/2014.9.SPINE131151
Garrison KR, Donell S, Ryder J, Shemilt I, Mugford M, Harvey I, Song F (2007) Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: a systematic review. Health Technol Assess 11(30):1–150, iii-iv
Gibson S, McLeod I, Wardlaw D, Urbaniak S (2002) Allograft versus autograft in instrumented posterolateral lumbar spinal fusion: a randomized control trial. Spine 27(15):1599–1603
Arrington ED, Smith WJ, Chambers HG, Bucknell AL, Davino NA (1996) Complications of iliac crest bone graft harvesting. Clin Orthop Relat Res ((329):300-309
Banwart JC, Asher MA, Hassanein RS (1995) Iliac crest bone graft harvest donor site morbidity. A statistical evaluation. Spine 20(9):1055–1060
Floyd T, Ohnmeiss D (2000) A meta-analysis of autograft versus allograft in anterior cervical fusion. Eur Spine J 9(5):398–403
Cahill KS, Chi JH, Day A, Claus EB (2009) Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures. JAMA 302(1):58–66. doi:10.1001/jama.2009.956
Carragee EJ, Hurwitz EL, Weiner BK (2011) A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J 11(6):471–491. doi:10.1016/j.spinee.2011.04.023
Hennessy KM, Pollot BE, Clem WC, Phipps MC, Sawyer AA, Culpepper BK, Bellis SL (2009) The effect of collagen I mimetic peptides on mesenchymal stem cell adhesion and differentiation, and on bone formation at hydroxyapatite surfaces. Biomaterials 30(10):1898–1909. doi:10.1016/j.biomaterials.2008.12.053
Li X, Contreras-Garcia A, LoVetri K, Yakandawala N, Wertheimer MR, De Crescenzo G, Hoemann CD (2015) Fusion peptide P15-CSP shows antibiofilm activity and pro-osteogenic activity when deposited as a coating on hydrophilic but not hydrophobic surfaces. J Biomed Mater Res A. doi:10.1002/jbm.a.35511
Kiely PD, Brecevich AT, Taher F, Nguyen JT, Cammisa FP, Abjornson C (2014) Evaluation of a new formulation of demineralized bone matrix putty in a rabbit posterolateral spinal fusion model. Spine J 14(9):2155–2163. doi:10.1016/j.spinee.2014.01.053
Eaton GJ, Zhang QS, Diallo C, Matsuzawa A, Ichijo H, Steinbeck MJ, Freeman TA (2014) Inhibition of apoptosis signal-regulating kinase 1 enhances endochondral bone formation by increasing chondrocyte survival. Cell Death Dis 5:e1522. doi:10.1038/cddis.2014.480
Myszka DG, Arulanantham PR, Sana T, Wu Z, Morton TA, Ciardelli TL (1996) Kinetic analysis of ligand binding to interleukin-2 receptor complexes created on an optical biosensor surface. Protein Sci 5(12):2468–2478. doi:10.1002/pro.5560051209
Hanks T, Atkinson BL (2004) Comparison of cell viability on anorganic bone matrix with or without P-15 cell binding peptide. Biomaterials 25(19):4831–4836. doi:10.1016/j.biomaterials.2003.12.007
Kubler A, Neugebauer J, Oh JH, Scheer M, Zoller JE (2004) Growth and proliferation of human osteoblasts on different bone graft substitutes: an in vitro study. Implant Dent 13(2):171–179
Fukumoto T, Sanyal A, Fitzsimmons JS, O’Driscoll SW (2002) Expression of beta1 integrins during periosteal chondrogenesis. Osteoarthritis Cartilage 10(2):135–144. doi:10.1053/joca.2001.0490
Kundu AK, Khatiwala CB, Putnam AJ (2009) Extracellular matrix remodeling, integrin expression, and downstream signaling pathways influence the osteogenic differentiation of mesenchymal stem cells on poly(lactide-co-glycolide) substrates. Tissue Eng Part A 15(2):273–283. doi:10.1089/ten.tea.2008.0055
Shih YR, Tseng KF, Lai HY, Lin CH, Lee OK (2011) Matrix stiffness regulation of integrin-mediated mechanotransduction during osteogenic differentiation of human mesenchymal stem cells. J Bone Miner Res 26(4):730–738. doi:10.1002/jbmr.278
Acknowledgements
We thank Dr. Irving Shapiro for his valuable discussions and manuscript revisions.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
No conflicts of interest exist for Jun Zhang, Peter Eisenhauer, Ozcan Kaya, Carol Diallo, Andrzej Fertala, or Theresa A Freeman.
Funding
This work was funded by Cerapedics, Inc.
Animal rights
All animal procedures were conducted under the approval of the Thomas Jefferson University Institutional Animal Care and Use Committee.
Rights and permissions
About this article
Cite this article
Zhang, J., Eisenhauer, P., Kaya, O. et al. P15 peptide stimulates chondrogenic commitment and endochondral ossification. International Orthopaedics (SICOT) 41, 1413–1422 (2017). https://doi.org/10.1007/s00264-017-3464-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00264-017-3464-8